Boston Scientific today announced the appointment of Kathleen Van Vlierberghe as the new vice president for the Peripheral Interventions division in Europe, Middle East and Africa (EMEA), effective 1 December 2024.
A news story on the company’s website details that Van Vlierberghe brings over 25 years of experience to her new position, having held various leadership roles across sales and marketing in the healthcare industry, including 19 years working at Boston Scientific.
Most recently, she led the Healthcare Solutions & Partnerships (HS&P) and Inside Sales division at Boston Scientific in EMEA, developing services and solutions that directly address some of the most pressing challenges in healthcare systems.
“I am excited to take on the challenge of leading the Peripheral Interventions business in EMEA,” said Van Vlierberghe. “It’s a privilege to be part of a company whose innovative solutions have helped transform the way healthcare professionals diagnose and treat people with vascular conditions and cancer, resulting in improved outcomes and quality of life, and reduced costs for healthcare services. I look forward to working collaboratively with the Peripheral Interventions team and other colleagues at Boston Scientific to make a positive difference to our customers and the patients they serve.”
